Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Julianne Chen"'
Autor:
Stefan O. Ciurea, Piyanuch Kongtim, Gabriela Rondon, Salman Otoukesh, Stephen J. Forman, Richard E. Champlin, Julianne Chen, Auayporn Nademanee, Michiko Taniguchi, Kai Cao, Ketevan Gendzekhadze, Fleur M. Aung, Jun Zou, Monzr M. Al Malki
Publikováno v:
Blood Advances. 5:4031-4043
Donor-specific anti-HLA antibodies (DSAs) are a major cause of engraftment failure in patients receiving haploidentical stem cell transplantation (HaploSCT). Effective treatments are needed for these patients, who often have no other donor options an
Autor:
Betul Oran, Ben C. Valdez, Partow Kebriaei, Rohtesh S. Mehta, Katy Rezvani, David Marin, Julianne Chen, Elizabeth J. Shpall, Amin M. Alousi, Uday R. Popat, Richard E. Champlin, Qaiser Bashir, Rima M. Saliba, Amanda Olson, Stefan O. Ciurea, Borje S. Andersson, Chitra Hosing
Publikováno v:
Cancer. 127:1598-1605
Background A myeloablative conditioning regimen can be safely given to older patients and those with comorbidities without increasing nonrelapse mortality (NRM) by fractionating the dose of intravenous busulfan. How this approach compares in efficacy
Autor:
Celina Ledesma, Gabriela Rondon, Ankur Varma, Rima M. Saliba, Stefan O. Ciurea, Richard E. Champlin, Julianne Chen, Samer A. Srour
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:1013-1020
Fluid overload (FO) grade ≥2 (more than 10% weight gain from baseline) has recently been recognized as an important toxicity associated with a high rate of nonrelapse mortality in recipients of allogeneic hematopoietic cell transplantation (AHCT).
Autor:
Julianne Chen, Qaiser Bashir, Samer A. Srour, Richard E. Champlin, Rohtesh S. Mehta, Betul Oran, Gabriela Rondon, Uday R. Popat, Ankur Varma, Stefan O. Ciurea, Amin M. Alousi, Piyanuch Kongtim, Naval Daver, Chitra Hosing, Amanda Olson, Marina Konopleva
Publikováno v:
Blood
The optimal conditioning regimen for older patients with acute myeloid leukemia (AML) remains unclear. In this study, we compared outcomes of AML patients >60 years of age undergoing allogenic hematopoietic stem cell transplantation at our institutio
Autor:
Usama Gergis, Julianne Chen, Wendy Stock, Sebastian Mayer, Stefan O. Ciurea, Gabriela Rondon, Hongtao Liu, Michael R. Bishop, Danielle Guarneri, Koen van Besien, Tsiporah B. Shore, Andrew S. Artz, Richard E. Champlin, Samer A. Srour
Publikováno v:
Blood Advances. 3:1858-1867
Haplo-identical transplant with posttransplant cyclophosphamide (haplo) and umbilical cord blood transplant supported by third-party CD34 cells (haplo-cord) are competing approaches to alternative donor transplant. We compared, in adults younger than
Autor:
Panupong Hansrivijit, Julianne Chen, Sharon R. Hymes, Uday R. Popat, Stefan O. Ciurea, Richard E. Champlin, Gabriela Rondon, Ana M. Ciurea, Chitra Hosing
Publikováno v:
American Journal of Hematology. 94:E176-E180
Autor:
Issa F. Khouri, David Marin, Richard E. Champlin, Muzaffar H. Qazilbash, Christina Ganesh, Uday R. Popat, Katayoun Rezvani, Samer A. Srour, Julianne Chen, Gheath Alatrash, Rohtesh S. Mehta, Stefan O. Ciurea, Jin Im, Amin M. Alousi, Partow Kebriaei, Jeffrey J. Molldrem, Yago Nieto, Qaiser Bashir, Betul Oran, Chitra Hosing, Paolo Anderlini, Borje S. Andersson, Elizabeth J. Shpall, Roland L. Bassett, Amanda Olson
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S446-S447
Context Fractionated busulfan/fludarabine (Bu-Flu) myeloablative conditioning yields low non-relapse mortality (NRM) in older patients and those with comorbidities after matched sibling (MSD) or unrelated (MUD) donor transplant (HCT). [Popat et al, L
Autor:
David Marin, Stefan O. Ciurea, Qaiser Bashir, Rohtesh S. Mehta, Elizabeth J. Shpall, Roland L. Bassett, Jin S. Im, Roy B. Jones, Simrit Parmar, Julianne Chen, Jitesh D. Kawedia, Amin M. Alousi, Sairah Ahmed, Geath Al-Atrash, Partow Kebriaei, Richard E. Champlin, Samer A. Srour, Benigno C. Valdez, Muzaffar H. Qazilbash, Katayoun Rezvani, Issa F. Khouri, Nina Shah, Uday R. Popat, Yago Nieto, Amanda Olson, Borje S. Andersson, Chitra Hosing, Paolo Anderlini, Betul Oran
Publikováno v:
The Lancet. Haematology, vol 5, iss 11
Summary Background Haemopoietic stem-cell transplantation (HCT) conditioning regimens that can reduce risk of relapse without increasing non-relapse mortality are needed. We aimed to test the safety of timed-sequential delivery of low-dose versus hig
Autor:
Rima M. Saliba, Amin M. Alousi, Uday R. Popat, Muzaffar H. Qazilbash, Simrit Parmar, Stefan O. Ciurea, Chitra Hosing, Gabriela Rondon, Mithun Vinod Shah, Partow Kebriaei, Betul Oran, Ioana Rus, Richard E. Champlin, Issa F. Khouri, Doris Soebbing, Julianne Chen
Publikováno v:
Bone Marrow Transplant
Allogeneic SCT for older patients remains challenging at least in part due to graft-versus-host disease (GVHD) and higher treatment-related mortality (TRM). We conducted a prospective pilot study primarily for older patients undergoing matched unrela
Autor:
Piyanuch Kongtim, Partow Kebriaei, Gheath Alatrash, Uday R. Popat, Issa F. Khouri, Richard E. Champlin, Jorge M. Ramos Perez, Denái R. Milton, Simrit Parmar, Qaiser Bashir, Gabriela Rondon, Julianne Chen, Amin M. Alousi, Abhishek Chilkulwar, Betul Oran, Borje S. Andersson, Stefan O. Ciurea, Chitra Hosing, Jin S. Im
Publikováno v:
Bone Marrow Transplant
Outcomes after allogeneic stem-cell transplantation (AHSCT) are influenced by both disease- and patient-related factors. Here, we developed a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), by combining the refined dise